Full-Time

Senior Quality Engineer

Deadline 6/20/27
Werfen

Werfen

1,001-5,000 employees

Global specialized diagnostics provider

No salary listed

No H1B Sponsorship

Norcross, GA, USA

In Person

Category
QA & Testing
Required Skills
Word/Pages/Docs
Risk Management
Excel/Numbers/Sheets

Get referred to Werfen

Find people who can refer or advise you

Requirements
  • Minimum of 5 years medical device experience in Quality or R&D Engineering position with risk management, design control and product development experience.
  • Experience in the IVD industry, preferred.
  • Bachelor's degree (BA/BS) from a four-year college or university; or equivalent combination of education and experience.
  • BS in Engineering or associated scientific discipline, preferred
  • Quality certification, such as CQE (Certified Quality Engineer) or CQA (Certified Quality Auditor), or ASQ, and/or SSBB, preferred
  • Proficient in Microsoft Word, Excel, and managing electronic data files.
  • Extensive hands-on experience with the ISO 14971 standard with demonstrated experience in implementing a device risk management process based on the standard and/or executing a RM.
  • Strong working knowledge of risk management, CAPA, and Design Controls.
  • Some experience in systems engineering and/or device development including connected systems and software as a medical device (SaMD)
Responsibilities
  • Lead risk management initiatives for the entire product lifecycle in accordance with ISO14971 and related regulatory requirements. Assure applicable quality decisions are derived from the appropriate risk management document in accordance to the quality system.
  • Independently manage and facilitate new risk assessments from initiation to completion working cross-functionally to develop risk management plans with key stakeholders that are robust and compliant with all procedural and regulatory requirements.
  • Collaborate at a systems level with R&D, Clinical, and other key functions to identify risks, implement risk control measures, and document a robust and living risk management file.
  • Review and provide feedback for changes to designs and processes and assess their impact to assure risk management requirements are met.
  • Support on-going product compliance technical documentation and on-going market authorizations through review and response to competent authority feedback in a timely manner.
  • Support teams to establish product development requirements e.g., Design Input Document, Design Verification and Validation requirements, Risk Management requirements, Usability requirements, CTQ Identification etc.
  • Support DHF content completion, collaboratively communicating and resolving regulatory compliance gaps.
  • Serve as a Quality Core Team member on sustaining product lifecycle project and new product development teams. Represent Quality for new and existing product improvement, manufacturing transfers, and quality plan initiatives.
  • Assist in the QA review and approval of process and equipment validation / qualifications (IQ, OQ, PQ).
  • Assist in QA review and approval of software user acceptance testing.
Desired Qualifications
  • Experience in the IVD industry preferred.
  • BS in Engineering preferred.
  • Quality certification, such as CQE (Certified Quality Engineer) or CQA (Certified Quality Auditor), or ASQ, and/or SSBB, preferred

Werfen focuses on in vitro diagnostics, offering specialized diagnostic solutions for healthcare. It provides tests and instruments for areas like hemostasis (blood clotting), acute care diagnostics, and autoimmunity, used by clinical laboratories to detect and monitor diseases. The company's products combine diagnostic assays, reagents, and instrumentation that run in laboratory workflows to produce actionable patient results. Werfen differentiates itself through its long-standing family-owned heritage, strategic growth including the 1991 acquisition of Instrumentation Laboratory, and a global footprint that spans 30 countries with active presence in more than 100 territories. The goal is to improve patient care by expanding access to accurate, high-quality diagnostic tools and services while maintaining a strong commitment to quality and specialized solutions.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$550M

Headquarters

Barcelona, Spain

Founded

1966

Get referred to Werfen

Find people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Transplant diagnostics offers a new growth lane through NGS-enabled assay validation.
  • The 169,000-square-foot Bedford R&D facility expands product development capacity.
  • Direct operations in 30 countries support broader commercialization across 100 territories.

What critics are saying

  • Sequencing-native competitors can bypass Werfen’s legacy transplant assay economics.
  • Omixon integration failure leaves Werfen underexposed in transplant diagnostics.
  • Global operations increase tender-loss exposure in large hospital procurement markets.

What makes Werfen unique

  • Werfen leads specialized diagnostics across hemostasis, acute care, autoimmunity, and transplant.
  • The October 16, 2024 Omixon acquisition expanded Werfen into NGS transplant diagnostics.
  • The May 29, 2026 Oxford Nanopore collaboration targets faster donor-recipient matching workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

TradingView
Mar 10th, 2026
AcouSort receives prepayment of royalties

AcouSort receives prepayment of royalties. AcouSort AB today announced the signing of an amendment to its license and distribution agreement with the leading blood-gas analyzer company, Werfen. Under the amendment, Werfen will prepay minimum royalties for 2027 and 2028. Together with Werfen's regular 2026 minimum royalty, the total sum payable to AcouSort in early 2026 amounts to approximately USD 1.3 million. "Based on our current cash position and this prepayment together with Werfen's regular 2026 minimum royalties alone will fund AcouSort into 2027," said AcouSort's CEO Dr. Torsten Freltoft. The original agreement was signed in spring 2018. Using AcouSort acoustofluidic background technology, the parties jointly developed the solution now implemented in Werfen's groundbreaking GEM Premier 7000 system for point-of-care blood gas analysis. The hemolysis detection in GEM Premier 7000 is based upon patented acoustofluidic technology for plasma separation, combined with photometric determination. In just 45 seconds, the GEM Premier 7000 detects hemolysis, while delivering a complete menu of blood-gas results (pH, pO2, pO2, sodium, potassium, ionized calcium, chloride, glucose, lactate, hematocrit, total hemoglobin, total bilirubin and CO-Oximetry). No other terms of the License and Distribution Agreement with Werfen have been changed. In terms of liquidity, the change takes effect within Q1, while revenue recognition occurs according to applicable accounting principles. This information is information that AcouSort is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-10 17:30 CET. FOR FURTHER INFORMATION ABOUT ACOUSORT, PLEASE CONTACT: Torsten Freltoft, CEO Telephone: +45 2045 0854 E-mail:[email protected] ABOUT ACOUSORT AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing - so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company's Certified Adviser is Tapper Partners AB. Attachments AcouSort receives prepayment of royalties

BioTecNika
Jan 5th, 2026
Biological Sciences Manufacturing Job at Werfen North America | Apply now

Biological sciences manufacturing job at Werfen North America | Apply now. Manufacturing Associate role at Werfen North America. Werfen North America is hiring for a Manufacturing Associate 1 position in San Diego, CA. This manufacturing job offers an opportunity to work in a regulated life sciences environment, supporting the production of advanced autoimmune diagnostic products used by clinicians worldwide. The Manufacturing Associate role is ideal for candidates seeking hands-on experience in diagnostic kit manufacturing while working with automated equipment and quality-driven processes. Job details: * Job Title: Manufacturing Associate 1 * Location: San Diego, California * Industry: Life Sciences / Diagnostics Manufacturing * Employment Type: Full-time * Department: Autoimmunity Manufacturing * Salary Range: $25/hr to $30/hr * Team: QUANTA Flash and Aptiva Manufacturing Team About Werfen North America: Werfen North America is a global leader in specialized diagnostics, focusing on autoimmune, hemostasis, acute care, and transfusion medicine. The company is committed to delivering high-quality diagnostic solutions that help healthcare professionals improve patient outcomes. Werfen North America operates under strict quality systems and regulatory standards, ensuring innovation, safety, and reliability across all manufacturing processes. Apply for more similar Manufacturing job offers in the USA. Educational requirements: * Bachelor's degree in biological or related sciences is required * Certificate program or Associate's degree with 3 - 4 years of relevant life sciences laboratory experience may be substituted * Relevant work experience may be considered in place of formal education at management's discretion Key responsibilities for Manufacturing Associate role: * Follow standard operating procedures and work instructions under supervision * Manufacture and test in-process components and diagnostic reagents * Participate in bulking and evaluation of reagents and components * Operate, clean, and maintain manufacturing equipment and instrumentation * Package and fill components according to manufacturing procedures * Maintain accurate Device History Records and related documentation * Assist with evaluation of raw materials when required * Ensure compliance with ISO, FDA, and Quality Management System regulations * Maintain a clean, safe, and organized lab and work environment * Reflect Werfen values in daily work and team interactions Skills required for Manufacturing Associate role: * Basic knowledge of laboratory practices and procedures * Understanding of Good Manufacturing Practices (GMP) * Strong attention to detail and quality standards * Ability to identify product defects or equipment issues * Problem-solving and troubleshooting skills * Effective time management skills * Ability to work collaboratively in a team environment * Willingness to learn and adapt in a regulated manufacturing setting Benefits of the Manufacturing Associate role: * Competitive hourly pay ranging from $25 to $30 per hour * Medical, dental, and vision insurance coverage * 401(k) retirement plan with employer match * Paid vacation and sick leave * Opportunity to work in a highly specialized diagnostic manufacturing environment * Career growth opportunities within Werfen North America

Citybuzz
Sep 9th, 2025
VolitionRx Partners with Werfen to Advance Diagnostic Testing for Antiphospholipid Syndrome

VolitionRx partners with Werfen to advance diagnostic testing for antiphospholipid syndrome.

The Bedford Citizen
Dec 11th, 2024
Werfen Opens New Building for Innovation at U.S. Technology Center on Hartwell Road

Werfen opens new building for innovation at U.S. Technology Center on Hartwell Road.

The Business Journals
Dec 3rd, 2024
Werfen to hire 'hundreds' in next few years as it expands in Bedford

Werfen to hire 'hundreds' in next few years as it expands in Bedford.